Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE
Brain, Behavior, and Immunity · 2025-03 · 125 · 355-370
DOI: 10.1016/j.bbi.2025.01.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025-03. Verfasst von Paola Bianchimano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Friedman Brain Institute, Icahn School of Medicine at Mount Sina…. Hauptthemen laut MEDLINE: Vancomycin, Encephalomyelitis, Autoimmune, Experimental, Astrocytes, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Icahn School of Medicine at Mount Sinai, Department of Neurology, College of Medicine, Medical University of South Carolina, National Multiple Sclerosis Society.
Abstract (Originalsprache)
Astrocytes play important roles in the central nervous system (CNS) during health and disease. Prior studies have shown that gut commensal-derived indole derivatives as well as secondary bile acids modulate astrocyte function during the late stage of EAE (recovery phase). Here we showed that administering vancomycin to mice starting during the early stage of EAE improved disease recovery, an effect that is mediated by the gut microbiota. We observed that 6 taxa within the Clostridia vadin BB60 group were enriched in vancomycin-treated mice compared to untreated EAE mice. Vancomycin-treated EAE mice also had elevated serum levels of the anti-inflammatory tryptophan-derived metabolite, indole-3-lactic acid and decreased levels of deoxycholic acid, a pro-inflammatory secondary bile acid. RNA sequencing revealed altered expression of several genes belonging to the mammalian target of rapamycin (mTOR) pathway in astrocytes obtained during the late stage of EAE from vancomycin-treated EAE mice. Furthermore, we observed a link between serum levels of indole derivatives and bile acids and expression of several genes belonging to the mTOR pathway. Interestingly, the mTOR signaling cascades have been implicated in several key biological processes including innate (e.g., astrocyte) immune responses as well as neuronal toxicity/degeneration. In addition, rapamycin, a specific inhibitor of mTOR, has been shown to inhibit the induction and progression of established EAE. Collectively, our findings suggest that the neuroprotective effect of vancomycin is at least partially mediated by indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Immunology Institute, Icahn School of…
- Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA.
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Dept of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Förderung
- Icahn School of Medicine at Mount Sinai
- Department of Neurology, College of Medicine, Medical University of South Carolina
- National Multiple Sclerosis Society
Zitieren
APA
Bianchimano, P., Leone, P., Smith, E. M., Gutierrez-Vazquez, C., Wind-Andersen, E., Bongers, G., Cristancho, S., Weiner, H. L., Clemente, J. C., & Tankou, S. K. (2025). Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE. Brain, Behavior, and Immunity, 125, 355-370. https://doi.org/10.1016/j.bbi.2025.01.006
Vancouver
Bianchimano P, Leone P, Smith EM, Gutierrez-Vazquez C, Wind-Andersen E, Bongers G, et al. Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE. Brain, Behavior, and Immunity. 2025;125:355-370. doi:10.1016/j.bbi.2025.01.006
BibTeX
@article{Bianchimano2025,
author = {Bianchimano, Paola and Leone, Paola and Smith, Emma M and Gutierrez-Vazquez, Cristina and Wind-Andersen, Erli and Bongers, Gerold and Cristancho, Sebastian and Weiner, Howard L and Clemente, Jose C and Tankou, Stephanie K},
title = {Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE},
journal = {Brain, Behavior, and Immunity},
year = {2025},
volume = {125},
pages = {355--370},
doi = {10.1016/j.bbi.2025.01.006}
}
EUVIMED